EKF Diagnostics (LON:EKF) Share Price Passes Above Two Hundred Day Moving Average – Here’s What Happened

EKF Diagnostics Holdings plc (LON:EKF) shares crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 26.77 and traded as high as GBX 27. EKF Diagnostics shares last traded at GBX 25.30, with a volume of 569,178 shares changing hands.

EKF Diagnostics Stock Performance

The firm has a market capitalization of £112.31 million, a price-to-earnings ratio of 19.26 and a beta of 0.54. The company has a debt-to-equity ratio of 1.56, a quick ratio of 1.77 and a current ratio of 4.62. The stock’s fifty day moving average is GBX 25.91 and its two-hundred day moving average is GBX 26.76.

Insider Buying and Selling at EKF Diagnostics

In other EKF Diagnostics news, insider Julian Baines bought 85,000 shares of the company’s stock in a transaction dated Monday, December 15th. The shares were acquired at an average cost of GBX 23 per share, with a total value of £19,550. 39.72% of the stock is owned by corporate insiders.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

? Point-of-Care analysers in the key areas of Hematology and Diabetes

? Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.